BRIEF-Diurnal Group says primary endpoint met in Infacort late-stage study By: Reuters: Company News July 11, 2016 at 02:48 AM EDT * Positive headline data from pivotal study for Infacort in Europe for paediatric adrenal insufficiency (AI) Read More >> Related Stocks: Renaissance IPO ETF Wisdomtree Global Ex-US Quality Div Growth Fund